Latest News

The Medical Services Advisory Committee's advice to Health Minister Mark Butler paints a dystopian picture of its decision-making. It has blithely dismissed the lives of newborn babies, which can only raise questions about its ongoing moral authority.

Health technology assessment agencies are under mounting and understandable pressure to deliver timely, high-quality evaluations in an era of rapidly evolving medical innovation.

Two Australian biotechnology companies have been recognised as regional leaders in innovation at the Asia Pacific Cell and Gene Therapy Excellence Awards 2025, held in Singapore, underscoring the nation’s growing influence in advanced therapies.

The advertising of prescription medicines is a ubiquitous feature of US media. However, the Trump administration has announced significant reforms that require the disclosure of complete safety warnings.

Chemist Warehouse has announced a new national partnership with DoorDash, giving customers across the country the ability to shop their favourite health, beauty, and personal care products from the convenience of their phone.

Australia’s cancer community will come together in Sydney this weekend for the 2025 PCPA Cancer Summit, the nation’s largest gathering of private cancer physicians, patient advocates, industry innovators, and policymakers.

General Manager Dr Nic Horridge said, “At Roche, we believe that health and sustainability are inseparable. The health of people depends on the health of the planet, and the choices we make today will shape both. This is both a profound responsibility and a core business strategy."

Artificial intelligence is edging closer to transforming the way new medicines are developed, with Australian company Pathkey.AI reporting encouraging results from its predictive platform, TrialKey.

The final episode of AstraZeneca’s TrailblAZers series features Professor John Skerritt, former Deputy Secretary of the Department of Health and Aged Care and TGA head, reflecting on lessons from the COVID-19 pandemic and the reforms needed to shape the future of healthcare delivery.

The Albanese Government’s Economic Reform Roundtable has generated a cascade of proposals from across departments and agencies about how to lift productivity and improve regulatory efficiency.

The US FDA has unveiled a significant regulatory advance with the introduction of its Rare Disease Evidence Principles, the latest example of a growing global momentum to accelerate the development and approval of therapies targeting rare diseases.

Mayne Pharma has moved to reassure staff and investors after media reports suggested its Salisbury manufacturing site in South Australia could be at risk of closure if its proposed merger with US company Cosette Pharmaceuticals goes ahead.